bioAffinity Technologies, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.19 | -$0.19 | -$0.19 |
Q2 2024 | 1 | -$0.17 | -$0.17 | -$0.17 |
Q3 2024 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q4 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
Q1 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
Q2 2025 | 1 | -$0.17 | -$0.17 | -$0.17 |
Q3 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
Q4 2025 | 1 | -$0.16 | -$0.16 | -$0.16 |
bioAffinity Technologies, Inc. Earnings Date And Information
bioAffinity Technologies, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.16 earnings per share for the quarter, missing analysts' consensus estimates of $-0.15 by $0.01. The company had revenue of 2.35 M for the quarter and had revenue of 2.53 M for the year. bioAffinity Technologies, Inc. has generated $-1 earnings per share over the last year ($-0.91 diluted earnings per share) and currently has a price-to-earnings ratio of -1.85. bioAffinity Technologies, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 28th, 2025 based on prior year's report dates.
bioAffinity Technologies, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2024 | Q3 2024 | -$0.15 | -$0.16 | -0.01 | $2.54 M | $2.35 M |
08/14/2024 | Q2 2024 | -$0.17 | -$0.19 | -0.02 | $2.45 M | $2.40 M |
05/15/2024 | Q1 2024 | -$0.15 | -$0.20 | -0.05 | $2.41 M | |
04/01/2024 | Q4 2023 | -$0.26 | $2.21 M | |||
11/14/2023 | Q3 2023 | -$0.26 | $100,000 | $298,484 | ||
08/14/2023 | Q2 2023 | -$0.20 | $19,738 | |||
05/15/2023 | Q1 2023 | -$0.18 | $921 | |||
03/31/2023 | Q4 2022 | -$0.20 | $2,346 | |||
11/14/2022 | Q3 2022 | -$1.17 | $1,150 | |||
06/29/2022 | Q2 2022 | -$0.18 | $1,306 | |||
03/30/2022 | Q1 2022 | -$0.55 | $0 | |||
12/31/2021 | Q4 2021 | -$2.08 | $0 | |||
09/30/2021 | Q3 2021 | -$0.57 | $0 | |||
06/29/2021 | Q2 2021 | $0.54 | $0 | |||
03/30/2021 | Q1 2021 | -$0.27 | $0 | |||
12/30/2020 | Q4 2020 | -$0.80 | $0 |
bioAffinity Technologies, Inc. Earnings: Frequently Asked Questions
-
When is bioAffinity Technologies, Inc.'s earnings date?
bioAffinity Technologies, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 28th, 2025 based off last year's report dates.
-
How can I listen to bioAffinity Technologies, Inc.'s earnings conference call?
The conference call for bioAffinity Technologies, Inc.'s latest earnings report can be listened to online.
-
How can I read bioAffinity Technologies, Inc.'s conference call transcript?
The conference call transcript for bioAffinity Technologies, Inc.'s latest earnings report can be read online.
-
How much revenue does bioAffinity Technologies, Inc. generate each year?
bioAffinity Technologies, Inc. (:BIAF) has a recorded annual revenue of $2.53 M.
-
How much profit does bioAffinity Technologies, Inc. generate each year?
bioAffinity Technologies, Inc. (:BIAF) has a recorded net income of $2.53 M. bioAffinity Technologies, Inc. has generated $-0.91 earnings per share over the last four quarters.
-
What is bioAffinity Technologies, Inc.'s price-to-earnings ratio?
bioAffinity Technologies, Inc. (:BIAF) has a price-to-earnings ratio of -1.85 and price/earnings-to-growth ratio is -0.17.